Both in Pharmaceuticals
Biote vs Lite Strategy
Over the past year BTMD returned −60.1% and LITS returned −49.6%; their daily moves had a correlation of 0.00.
BTMD −60.1% LITS −49.6%Growth of $1, one year, split-adjusted
| Metric | BTMD | LITS |
|---|---|---|
| Price | $1.13 | $0.9677 |
| Market cap | $32.4M | $29.4M |
| Today | +1.80% | −13.60% |
| 1 month | −1.7% | −29.9% |
| 6 months | −46.4% | −15.1% |
| Year to date | −56.5% | −26.7% |
| 1 year | −59.4% | −50.4% |
| Revenue growth (YoY) | −9.5% | — |
| Gross margin | 65.4% | — |
| Net margin | −14.8% | — |
| P/E (TTM) | 5.5× | — |
| Price / sales | 0.2× | — |
| Net cash | -$110.3M | $5.7M |
| Dividend yield | — | — |
| Volatility (60d) | 67.3% | 85.0% |
| Short % of float | 5.4% | 0.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).